DMH-25

DMH25 is a novel, covalent, and potent mTOR inhibitor. It demonstrates significant antitumor efficacy in vivo, particularly against triple-negative breast cancer models. This small molecule is a valuable research tool for studying mTOR signaling and oncology in both cellular and animal studies.